Related Experiment Video
Updated: Jul 18, 2026
07:27
The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Advances in carnitine in chronic uremia
Gianfranco Guarnieri1, Gianni Biolo, Pierandrea Vinci
1Department of Clinical, Morphological and Technological Sciences, Division of Internal Medicine, University of Trieste, Trieste, Italy. guarnier@units.it
Summary
Carnitine supplementation helps hemodialysis patients by improving their response to erythropoietin and potentially benefiting their overall health. This essential metabolite aids mitochondrial function and prevents nutrient depletion during dialysis.
Area of Science:
- Biochemistry
- Metabolic Medicine
- Nephrology
Background:
- Carnitine is vital for mitochondrial fatty acid transport and energy metabolism.
- Carnitine deficiency can cause metabolic disturbances.
- Hemodialysis patients may experience carnitine depletion due to loss during treatment.
Purpose of the Study:
- To evaluate the effects of carnitine supplementation in patients undergoing maintenance hemodialysis.
- To assess the potential clinical benefits of carnitine in this patient population.
Main Methods:
- Review of existing literature on carnitine supplementation in hemodialysis patients.
- Analysis of studies examining carnitine's impact on hematologic status, exercise tolerance, and other clinical parameters.
Main Results:
- Carnitine supplementation may improve response to erythropoietin, enhancing hematologic status.
- Supplementation is associated with improved exercise tolerance and reduced intradialytic symptoms.
- Potential benefits include enhanced insulin sensitivity, antioxidant status, protein balance, lipid profile, and cardiac function.
Conclusions:
- Carnitine supplementation can counteract depletion in hemodialysis patients.
- It offers potential clinical benefits, particularly for those not responding to standard therapies.
- Carnitine is a valuable therapeutic option for selected dialysis patients.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:23Urea Cycle
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...